Cristina L. Cebotaru

Cluj-napoca, CJ, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Challenges in the Management of Stage IV Clear Cell Sarcoma of Soft Tissue in Young Adults: Case Report and Review of the Literature.

Challenges in the Management of Stage IV Clear Cell Sarcoma of Soft Tissue in Young Adults: Case Report and Review of the Literature.

Journal: Case reports in oncology

Published: April 19, 2024

Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-controlled, randomized, phase II study.

Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-controlled, randomized, phase II study.

Journal: ESMO open

Published: July 01, 2021

Second-line lenvatinib in patients with recurrent endometrial cancer.

Second-line lenvatinib in patients with recurrent endometrial cancer.

Journal: Gynecologic oncology

Published: December 03, 2019

Intracranial immature teratoma with a primitive neuroectodermal malignant transformation - case report and review of the literature.

Intracranial immature teratoma with a primitive neuroectodermal malignant transformation - case report and review of the literature.

Journal: Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie

Published: February 09, 2017

Circulating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A review.

Circulating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A review.

Journal: Clujul medical (1957)

Published: September 10, 2015

Retroperitoneal perirenal myxoid liposarcoma.

Retroperitoneal perirenal myxoid liposarcoma.

Journal: Journal of surgical case reports

Published: March 10, 2015

Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non-small-cell lung cancer.

Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non-small-cell lung cancer.

Journal: BMC cancer

Published: September 09, 2014

Phase II trial of mapatumumab, a fully human agonist monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1), in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.

Phase II trial of mapatumumab, a fully human agonist monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1), in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.

Journal: Clinical lung cancer

Published: September 24, 2013

Showing 1-8 of 8

Last Updated: 09/26/2026